| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |